DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

Information source: Emory University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Congenital Heart Disease

Intervention: Blood draws (Other)

Phase: N/A

Status: Terminated

Sponsored by: Emory University

Official(s) and/or principal investigator(s):
Kiran Hebbar, MBBS, Principal Investigator, Affiliation: Emory University & Children's Healthcare of Atlanta


The goal of this study is to evaluate specific hormone levels in children undergoing heart surgery in order to identify patterns associated with any unstable vital signs. The data collected will provide preliminary answers to the question "Are hormone values a determining factor for drug administration and dosing levels?" and help establish the benefits of routine steroid and hormone administration. Sixty subjects will be enrolled. Blood samples will be drawn before the surgery,and again nine hours after surgery for analysis. Other patient data such as medications, vital signs, routine lab values and treatments will also be analyzed. As our current standard of care includes routine doses of steroids, we believe this study will increase our general knowledge and improve the care of these critically ill children. The study will also provide the foundation needed for grant support from the American Heart Association, allowing for future larger scale studies.

Clinical Details

Official title: Prevalence of Neuroendocrine Dysfunction in the Pediatric Cardiopulmonary Bypass Patient

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome: NO Outcomes - Study Terminated Without Data.


Minimum age: N/A. Maximum age: 1 Year. Gender(s): Both.


Inclusion Criteria:

- Children with congenital heart disease requiring cardiopulmonary bypass(CPB) surgery

less than 1 year of age admitted to the cardiac intensive care unit (CICU) preoperatively, who required blood sampling as part of their care.

- Subject must have arterial or central venous lines to be enrolled.

- Subject must have a documented weight of 2. 5 Kilograms or greater.

- Subjects' legal guardian shall possess the ability to understand the purposes and

risks of the study and provide an informed consent signature. Exclusion Criteria:

- Medical urgency preventing timely administration of the consenting process.

- Any condition that, in the opinion of the attending physician, would place the

patient at undue risk by participating. Specific conditions might include, but are not limited to, anemia or coagulopathy.

- Have given steroids intravenously (IV) or oral steroids within the last month.

- Have a preexisting neuroendocrine disorder.

- Have been treated with antipsychotic medication.

- Have human immunodeficiency virus (HIV).

- Have received etomidate for intubation.

- Other technical considerations that would prevent acquisition of sufficient samples

OR inability / unwillingness of the legal guardian to provide consent.

Locations and Contacts

Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia 30322, United States
Additional Information

Starting date: March 2009
Last updated: November 18, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017